|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/14 | |
| A61K 31/4184 | |||
| A61K 31/4188 | |||
| C07D 487/04 | |||
| A61P 37/00 |
| (11) | Number of the document | 3331889 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16748045.8 |
| Date of filing the European patent application | 2016-08-02 | |
| (97) | Date of publication of the European application | 2018-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/045104 |
| Date | 2016-08-02 |
| (87) | Number | WO 2017/023902 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 201562200415 P | 2015-08-03 | US |
| (72) |
XIAO, Hai-Yun, US
DHAR, Murali T.G., US
JIANG, Bin, US
DUAN, Jingwu, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA |
| CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA |